Cargando…
WCN23-1131 RISK OF AKI IN COVID-19 PATIENTS: CLINICAL COURSE AND OUTCOMES
Autores principales: | Flores Fonseca MD, M.M., Gudiño Nuñez, M.J., Gonzalez Franco, M., Rodriguez Ugarte, V., Bautista Melo, B., Baltazar Rodriguez, L.M., Diaz Burke, Y., Ramirez Anguiano, A.C., Velasco Ramirez, S.F. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Published by Elsevier Inc.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10025617/ http://dx.doi.org/10.1016/j.ekir.2023.02.994 |
Ejemplares similares
-
WCN23-0213 PROXIMAL TUBULAR DYSFUNCTION AS A PREDICTOR OF AKI IN HOSPITALIZED COVID-19 PATIENTS
por: ALIMUL BARI, A., et al.
Publicado: (2023) -
WCN23-0317 AKI IN HOSPITALIZED COVID-19 PATIENTS- AN EPIDEMIOLOGY STUDY IN A TERTIARY CENTER
por: OOI, S., et al.
Publicado: (2023) -
WCN23-0857 Utility of urinary biomarkers for diagnosis of acute kidney injury (AKI) in COVID-19
por: SAMRA, T., et al.
Publicado: (2023) -
WCN23-0312 THE SIGNIFICANCE OF EPIDERMAL GROWTH FACTOR AND OTHER URINARY CYTOKINES SINCE SUBCLINICAL AKI IN PATIENTS WITH COVID-19
por: CASAS, G., et al.
Publicado: (2023) -
WCN23-0017 A CASE REPORT OF ‘RETROPERITONEAL FIBROSIS CAUSING RENOVASCULAR HYPERTENSION’ ASSOCIATED WITH SARS-CoV2
por: Cheema, S., et al.
Publicado: (2023)